These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17450178)

  • 1. Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation.
    Mizutani E; Narimatsu H; Murata M; Tomita A; Kiyoi H; Naoe T
    Bone Marrow Transplant; 2007 Jul; 40(1):85-7. PubMed ID: 17450178
    [No Abstract]   [Full Text] [Related]  

  • 2. High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
    Narimatsu H; Watanabe M; Kohno A; Sugimoto K; Kuwatsuka Y; Uchida T; Murata M; Miyamura K; Morishita Y;
    Bone Marrow Transplant; 2008 Apr; 41(8):753-6. PubMed ID: 18195683
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
    Tachikawa Y; Abe Y; Choi I; Ohtsuka R; Nagasawa E; Shibata K; Nishimura J; Nawata H; Muta K
    Fukuoka Igaku Zasshi; 2005 Nov; 96(11):378-82. PubMed ID: 16502857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
    Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
    Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBT.
    Tanaka H; Ohwada C; Sakaida E; Takeda Y; Abe D; Oda K; Ozawa S; Shimizu N; Masuda S; Cho R; Nishimura M; Saito Y; Nakaseko C
    Bone Marrow Transplant; 2007 Nov; 40(10):995-6. PubMed ID: 17768388
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient.
    Shimada K; Narimatsu H; Morishita Y; Kohno A; Saito S; Kato Y
    Bone Marrow Transplant; 2006 Apr; 37(8):787-8. PubMed ID: 16501589
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
    Ford CD; Asch J; Pulsipher M; Petersen FB
    Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
    Kharfan-Dabaja MA; Otrock ZK; Bacigalupo A; Mahfouz RA; Geara F; Bazarbachi A
    Bone Marrow Transplant; 2012 Sep; 47(9):1254-5. PubMed ID: 22246089
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis.
    Shimizu I; Kobayashi H; Nasu K; Otsuki F; Ueki T; Sumi M; Ueno M; Ichikawa N; Nakao S
    Bone Marrow Transplant; 2009 Nov; 44(9):617-8. PubMed ID: 19349955
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.
    Brown M; Myers D; Shreve N; Rahmetullah R; Radhi M
    Bone Marrow Transplant; 2016 May; 51(5):744-6. PubMed ID: 26808569
    [No Abstract]   [Full Text] [Related]  

  • 15. Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia.
    Cho HW; Ju HY; Hyun JK; Lee JW; Sung KW; Koo HH; Lim DH; Yoo KH
    J Korean Med Sci; 2021 May; 36(19):e128. PubMed ID: 34002548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
    Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
    Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
    Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
    Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Kuroki F; Ito S; Yokota S
    Rinsho Ketsueki; 2007 Jun; 48(6):495-500. PubMed ID: 17633098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful engraftment of the second reduced-intensity conditioning cord blood transplantation (CBT) for a patient who developed graft rejection and infectious complications after the first CBT for AML.
    Nakamura Y; Tanaka Y; Ando T; Sato Y; Yujiri T; Tanizawa Y
    Bone Marrow Transplant; 2007 Aug; 40(4):395-6. PubMed ID: 17572713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.